Securities code: 002900 securities abbreviation: Harbin Medisan Pharmaceutical Co.Ltd(002900) Announcement No.: 2022-005 Harbin Medisan Pharmaceutical Co.Ltd(002900)
Announcement of resolutions of the 18th meeting of the third board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
1. The notice of the 18th meeting of the third board of directors (hereinafter referred to as “the meeting”) of Harbin Medisan Pharmaceutical Co.Ltd(002900) (hereinafter referred to as “the company”) was sent to all directors in writing and e-mail on January 24, 2022.
2. The meeting was held by means of communication voting at 10:00 a.m. on January 27, 2022.
3. Nine directors should attend the meeting, and nine directors actually attended and voted.
4. Mr. Qin Jianfei, chairman of the company, presided over the meeting, and the supervisors and general manager of the company attended the meeting as nonvoting delegates. 5. The notice, convening and convening of this meeting comply with the company law of the people’s Republic of China and other laws, administrative regulations, departmental rules, normative documents and the relevant provisions of the Harbin Medisan Pharmaceutical Co.Ltd(002900) articles of association.
2、 Deliberations of the board meeting
The meeting considered and passed the following proposals:
1. Deliberated and passed the proposal on adjusting the company’s organizational structure
Voting: 9 valid votes, 9 in favor, 0 against and 0 abstention.
Voting result: adopted.
For details of the announcement on adjusting the company’s organizational structure, please refer to the announcement published in China Securities Journal, Shanghai Securities News, securities times, securities daily and cninfo on the same day（ http://www.cn.info.com.cn. ）Relevant announcements on.
3、 Documents for future reference 1. Resolutions of the 18th meeting of the third board of directors of the company. It is hereby announced.
Board of directors February 28, 202900
